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Abstract: Cardiovascular diseases are the main cause of death worldwide, with sleep disordered
breathing being a further aggravating factor. Respiratory illnesses are the third leading cause of death
amongst the noncommunicable diseases. The current COVID-19 pandemic, however, also highlights
the impact of communicable respiratory syndromes. In the clinical routine, prolonged postanesthetic
respiratory instability worsens the patient outcome. Even though early and continuous, long-term
cardiorespiratory monitoring has been proposed or even proven to be beneficial in several situations,
implementations thereof are sparse. We employed our recently presented, multimodal patch stethoscope
to estimate Einthoven electrocardiogram (ECG) Lead I and II from a single 55 mm ECG lead. Using
the stethoscope and ECG subsystems, the pre-ejection period (PEP) and left ventricular ejection time
(LVET) were estimated. ECG-derived respiration techniques were used in conjunction with a novel,
phonocardiogram-derived respiration approach to extract respiratory parameters. Medical-grade
references were the SOMNOmedics SOMNO HDTM and Osypka ICON-CoreTM. In a study including 10
healthy subjects, we analyzed the performances in the supine, lateral, and prone position. Einthoven I
and II estimations yielded correlations exceeding 0.97. LVET and PEP estimation errors were 10% and
21%, respectively. Respiratory rates were estimated with mean absolute errors below 1.2 bpm, and the
respiratory signal yielded a correlation of 0.66. We conclude that the estimation of ECG, PEP, LVET, and
respiratory parameters is feasible using a wearable, multimodal acquisition device and encourage further
research in multimodal signal fusion for respiratory signal estimation.
Keywords: ECG; PEP; LVET; respiration rate; wearable cardiorespiratory monitoring; patch; digital
stethoscope; ECG-derived respiration; phonocardiogram-derived respiration; neural network
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1. Introduction
1.1. Clinical Background and State-of-the-Art
Of all worldwide deaths, 31.3% were caused by cardiovascular diseases (CVD) in 2016, making
them the most common cause of death. Amongst the noncommunicable diseases, respiratory issues are
the third leading cause of death worldwide with 6.7% [1]. It is now a well-known fact, however, that
respiration-related illnesses can also significantly increase the risk for CVD and other diseases. Especially
in the case of obstructive sleep apnea (OSA), close relations to increased CVD such as hypertension [2]
and atrial fibrillation [3] have been reported. At the same time, OSA is one of the most common sleep
disorders with an estimated 936 million people affected worldwide [4]. Respiratory parameters also play an
important role in the clinical, postanesthetic routine. It has been shown that respiratory complications are
major causes of prolonged hospital stay, poor overall outcomes, and increased mortality [5–7]. Outbreaks
of respiratory syndromes such as severe acute respiratory syndrome (SARS), Middle East respiratory
syndrome (MERS), and the currently ongoing COVID-19 pandemic [8] further emphasize the importance
of tools for an early diagnosis [9]. From the described situation, it becomes evident that cardiorespiratory
monitoring is one of the major fields to be addressed in the future.
During the last two decades, rapid developments in battery technology, low-power embedded
processors, and integrated sensors have led to technologies being increasingly wearable. Current
generations of wearable, noninvasive biosignal acquisition systems can be roughly categorized by
their runtime and the physiological parameters of interest [10], as well as their implementation,
biosignal selection, and whether or not they are organized into networks [11]. The physiological
parameters addressed are oriented on the identified large health issues of the present and future.
It is therefore consequent that a large number of systems focus on the cardiovascular system, activity
measures, the respiratory system, and the metabolism. The selection of biosignals varies with the
use-case and implementation. Commonly found modalities are the ECG, accelerometry, gyrometry,
photoplethysmography, galvanic skin response, body temperature, bioimpedance methods, blood glucose,
and ambient parameters. Systems can be designed to operate on their own or in networks such as body
area networks, body sensor networks, or wireless sensor networks. Due to a variety of materials available
ranging from standard printed circuit boards (PCB) and flexible PCBs to textile integrated electronics [12],
implementations of wearable biosignal acquisition systems usually range from sensor shirts over chest
straps, wrist-bands, and necklaces, to small adhesive patches implemented using flexible materials [13].
The electrocardiogram (ECG) is widely considered as a gold standard for the non-invasive assessment
of the cardiovascular system and detection of CVD. The resting ECG is an effective screening method for
athletes [14] and a tool for cardiovascular risk assessment in asymptomatic adults [15]. In a chest pain
emergency situation, obtaining an ECG within 10 min is recommended [16]. Transient symptoms such as
arrhythmias are monitored using 24 h Holter ECG systems or over days or weeks using long-term systems,
especially preceding and following ablation therapy [17]. Most of these systems still follow a traditional
lead configuration with large inter-electrode spacing. It has been shown, however, that it is possible to
synthesize multiple ECG leads from only a few standard measurements [18]. Only a few studies have
investigated the possibility to obtain standard leads from short inter-electrode ECG lead systems [19],
but some findings suggest that even a 12-channel ECG reconstruction could be possible using a single
5 cm patch device, which incorporates multiple small-distance ECG lead recordings [20]. Even though the
lead field theory seems to support the concept of short-distance ECG recordings, no recommendations on
application-specific placements have been established yet, and the evaluation of methods beyond ECG
lead estimation from short-distance ECG leads is yet sparse [21].
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While the ECG reflects the electrical properties of the heart, structural abnormalities or defects do
not necessarily manifest themselves in the ECG, but in abnormal heart sounds and murmurs [22]. These
changes can be assessed by the phonocardiogram (PCG). While stethoscope auscultation is a valuable
and oftentimes first applied tool in primary health care, its digitization is a relatively recent development
leading to applications including classification of mitral valve prolapse [23] and the detection of other
abnormal heart sounds [24]. Currently available digital stethoscopes are designed close to the traditional
implementation [25], with a few exceptions lately emerging [26]. To the best knowledge of the authors, no
wearable digital stethoscope implementation was available until very recently.
Combining ECG and PCG signals, systolic time intervals (STI) can be derived. STIs are known to
relate closely to ventricular failure, the rate of ventricular pressure rise, preload, and other indices [27].
Especially the pre-ejection period (PEP) and the left ventricular ejection time (LVET) have been found to
be closely related to these measures. STIs provide insights into the temporal structure of the mechanical
heart activity and can therefore contribute additional vital information about the cardiovascular system.
Several approaches to assessing STIs are available, including echocardiography, impedance cardiography
(ICG), photoplethysmography, seismocardiography (SCG), and PCG. Considering echocardiography as
the reference, the PCG approach outperforms other methods when PEP and LVET are to be estimated [28],
and PCG and SCG deliver comparable results estimating total systolic time and the electromechanical
delay [29]. Therefore, several approaches of estimating STI from ECG and PCG have been reported [30,31].
Despite the work available on PEP estimation using the PCG, there seem to be diverging opinions about
whether or not PCG can be used for PEP estimation in principle [29,32].
Assessing the function of the respiratory system is usually bound to obtrusive sensors. Especially
in the context of sleep testing, flow sensors such as face masks or nasal cannula pressure sensors
and effort sensors such as respiratory inductance plethysmography chest and abdominal belts are still
recommended [33]. While the development of an unobtrusive home sleep test system took important steps
forward, the expert opinion remains that further research regarding the minimum number of parameters
and methods of signal acquisitions is required [34]. A promising technique for unobtrusive respiratory
signal estimation is ECG-derived respiration (EDR), which is commonly used in conjunction with other
signal modalities such as photoplethysmography (PPG) [35]. An obvious advantage of EDR in the case of
an available ECG is that no additional sensor is needed to estimate respiratory parameters. It is widely
accepted that the ECG is modulated in three main aspects by the respiration: baseline wandering, heart
rate, and QRS morphology. EDR methods aim to use one or more of these measures to estimate respiratory
parameters. The extraction of the heart rate is less sensitive to ECG position and electrode distances due
to the electrically strong QRS complex. The usability of morphological features, however, more strongly
depends on the lead location. Especially in the context of small sensor systems placed at non-standard
positions, this becomes important [36].
Besides ECG and PPG based methods, several additional concepts of estimating respiratory
parameters have emerged. Other approaches used to estimate respiratory signals include respiratory
sounds, breathing air temperature, humidity and components [37], the oscillometric cuff pressure,
Korotkoff sounds, as well as the seismocardiogram (SCG) [38]. For the latter, it has been shown that
the morphology of the vibrational cardiac waveforms varies with the respiratory volume [39,40], and
methods of extracting respiratory phases [41,42], effort [43] and breathing states such as normal, breathless,
long, and labored [44] have been proposed. However, the interindividual morphological variations,
as well as dependencies on numerous parameters including subject position, are still challenging [45].
SCG and PCG are closely related [46], with differences mostly defined by their frequency ranges [47].
However, the application of PCG signals for respiratory signal estimation seems not to have been proposed
yet. The authors assume that one reason is the unavailability of appropriate long-term monitoring
stethoscope systems.
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1.2. Scope of the Presented Work
With strong evidence that continuous, long-term cardiovascular and respiratory monitoring can
improve clinical outcome [48], optimize therapy success evaluation [49], and be an effective strategy to
assess sleep apnea [50], it is time to introduce a paradigm shift. Unimodal acquisition systems, such as
wearable ECGs, can provide vital information. The real strength of wearable monitoring, however, lies
beyond: in multimodality matched with unobtrusiveness. We recently presented a wearable, multimodal
digital stethoscope patch, shown in Figure 1. The system incorporates single-lead ECG and impedance
pneumography at an electrode distance of 55 mm, 9-axial magnetic, angular rate and gravity (MARG)
sensors, a digital stethoscope and ambient sound recording in a 60 mm × 70 mm × 6 mm device [51].
In its current implementation, the system employs a thin 450 mAh lithium-polymer battery and realized
runtimes exceeding 10 h even though not being optimized for low energy consumption yet.
Figure 1. The wearable multimodal stethoscope patch. (a) Front view. (b) Back view with ECG / IP
electrode connectors and 28 mm infant stethoscope membrane.
In this work, we present three distinct cardiovascular and respiratory monitoring applications using
the ECG and digital stethoscope subsystems of our novel, multimodal wearable. We start by evaluating
the performance of estimating standard Einthoven leads from the single, 55 mm short-distance lead
implemented in the patch. Using the derived standard ECG leads, we classify the ECG fiducial points and
the PCG S1 and S2 peaks in the stethoscope signal. This information is used to estimate PEP and LVET.
Finally, respiratory signals and rates are estimated using ECG-derived respiration techniques combined
with a novel phonocardiogram-derived respiration (PDR) approach. Figure 2 gives a simplified overview
of the processing steps. We evaluate our approaches using two commercially available reference systems
(SOMNOmedics SOMNO HDTM and Osypka ICON-CoreTM) acquiring reference ECG signals, PEP, LVET,
and respiratory flow in a study including 10 healthy subjects with 33 min measurements each in different
body positions. We aim to accelerate the development of truly multimodal, wearable biosignal acquisition
and processing towards holistic long-term monitoring concepts.
Figure 2. Overview of the processing steps and estimated modalities throughout this work.
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2. Materials and Methods
2.1. Data Acquisition
The data for the presented work were acquired using our previously described wireless, multimodal
stethoscope patch shown in Figure 1. Out of the numerous sensors provided by the patch, we used the
ECG (1 kHz, 24 bit) and the digital stethoscope (10 kHz, 32 bit) for the applications presented here. Two
commercially available biosignal acquisition systems were used alongside the patch to acquire reference
data. The Osypka Medical GmbH ICON-CoreTM monitor was employed to record a bioimpedance signal
(200 Hz), an ECG corresponding to the Einthoven II lead (200 Hz), as well as beat-to-beat reference values
for PEP and LVET (resolution of 5 ms). The ICON-Core calculates the PEP as the time between the Q-peak
in the ECG and the B-point in the ICG signal. The LVET is calculated as the time between the B-point
and the X-point in the ICG. Figure 3a visualizes the PEP and LVET definitions used throughout this work.
The SOMNOmedics GmbH SOMNO HDTM polygraphy system was used to record reference respiratory
flow (512 Hz) using a pneumotachometer and facial mask, as well as a second ECG corresponding to
Einthoven I (1024 Hz). The patch system was attached at an angle of 45° between the first and second
intercostal space (ICS) at the right midclavicular line. The four electrodes of the ICON-Core were attached
at the first and second ICS on the sternum, as well as at the fifth and sixth ICS on the left midaxillary line.
The SOMNO HD ECG electrodes were placed according to the Einthoven I lead, and the facial mask was
secured using appropriate rubber material. Figure 3b gives a visual representation of the sensor placement.
We conducted a study including 10 subjects (26 ± 2 years, 2 female), which was approved by the TU
Berlin Ethics Committee of the Department of Psychology and Ergonomics under the tracking number
KL_01_20180117. Each subject was instructed by a custom app to breathe pre-defined, 11 min long patterns
of varying combinations of breathing frequencies (8, 16, 24 breaths per minute (bpm)), breathing depths
(shallow, normal), and 30 s simulated apnea (breath holding). This pattern sequence was recorded in the
supine, lateral, and prone position, resulting in 33 min of data per subject.
Figure 3. (a) PEP and LVET definitions. (b) Sensor placement throughout the study.
2.2. Regression Models and Cross-Validation
Throughout our work, we used three model classes for regression analysis: polynomials up to the
order of three, multi-layer perceptrons (MLP) with two to three hidden layers with two to fifteen neurons
each, and time-delay neural networks (TDNN) with the same layer configuration as the MLPs and input
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delay lines with lags between 1 and 1 to 200 taps. For multiple-input regression problems in the polynomial
case, multiple linear regression with polynomial models without cross-terms was employed, following:
y = a0 +
M
∑
m=1
K
∑
k=1
amkxmk , (1)
where xmk are the K independent variables of the power of one to the order of the polynomial M
and a0 is the constant. Figure 4 gives a visual representation of the neural network model configurations,
which can be easily expanded for multiple input regression problems.
Prior to training, training and testing observation and target data were normalized to zero mean and
unit variance. The mean and variance of the training target data were saved along with the trained model
as an estimate of the target distribution. In the test phase, the estimated target data were denormalized
using the distribution estimated in the training phase.
Figure 4. Neural network regression model configurations used throughout this work: (a) multi-layer
perceptrons. (b) time-delay neural networks.
All reported regression performances were obtained using an nCV-times nested forward chaining
cross-validation scheme. Figure 5 gives an Example for nCV = 3. Data were divided into nCV + 1
continuous sections without randomization. In the first validation round, the first section was used for
training and the second section for testing. In the next validation round, the training data consisted of all
the previously used training and testing sections, thus Sections 1 and 2. The test dataset consisted of the
next section, thus the third. This scheme was followed until all data were used. The mean and standard
deviation of the performance distribution are reported.
Figure 5. Example of the data split in forward-chaining cross-validation with nCV = 3 validation rounds.
Sensors 2020, 20, 2033 7 of 21
2.3. Performance Metrics
We used several metrics throughout our work to characterize the performance of estimations Est
relative to reference values Re f . The systematic error, or bias, was characterized using the mean error,
ME =
1
N
N
∑
i=1
Est(i)− Re f (i), (2)
while absolute errors were evaluated by the mean absolute error:
MAE =
1
N
N
∑
i=1
|Est(i)− Re f (i)|. (3)
In order to provide more population independent measures, we provided two relative, percentage
metrics chosen based on the type of data. For strictly non-zero data, we employed the mean absolute
percentage error:
MAPE =
1
N
N
∑
i=1
∣∣∣∣Est(i)− Re f (i)Re f (i)
∣∣∣∣ ∗ 100 %. (4)
For data including or approaching zero, such as ECG or respiratory signals, the normalized mean
squared error:
NMSE = ∑
N
i=1(Est(i)− Re f (i))2
∑Ni=1 Re f (i)2
∗ 100 % (5)
was employed to avoid singularity effects. In order to assess correlations, we used the Pearson linear
correlation r. Model selection was performed using the Bayesian information criterion:
BIC = N ∗ ln(SSE
N
) + ln(N) ∗ K, (6)
where SSE is the sum of squared errors, N is the number of observations, and K is the model order.
2.4. Einthoven Lead Estimation
Prior to the ECG lead estimation using the patch ECG, all three ECG signals were resampled to 200 Hz
and low-pass filtered at a corner frequency of 75 Hz using a zero-phase FIR filter with an order of 400.
Their baselines were removed by subtracting 0.5 Hz moving-average filtered signals. Finally, a 50 Hz notch
filter with a quality factor of q = 10 was employed to reject power line interference.
Using the three models and cross-validation schemes discussed, the patch ECG signals were fitted to
the SOMNO HD ECG signal to estimate Einthoven Lead I and to the ICON-Core ECG signal to estimate
Einthoven Lead II. Models were fitted for each proband and each position individually, and the selection of
the model parameters was based on the minimum of the BIC of the validation data, as given in Equation (6).
2.5. PEP and LVET Estimation
Prior to the PEP and LVET estimation using the patch ECG and patch stethoscope signals, the patch
ECG signals were processed as described in Section 2.4. The stethoscope signals were band-pass filtered at
corner frequencies of 5 Hz and 250 Hz using a zero-phase FIR filter with an order of 400 and resampled to
5 kHz.
Due to the definition of the PEP, the non-standard ECG lead recorded by the patch was suboptimal for
its estimation. It was therefore transformed into the Einthoven II lead using the model derived in Section 2.4.
Sensors 2020, 20, 2033 8 of 21
The ECG R-peak was then detected using the Pan–Tompkins ECG peak detection algorithm [52]. From the
R-peak, P, Q, S, and T were identified using successive rule based windowing and local maximum and
minimum detection. The start, end, and peak of S1 and S2 within the stethoscope PCG signals were
detected using a modified approach of the empirical wavelet transform and the instantaneous phase based
method proposed by Varghees et al. [53], combined with an ECG based PCG peak classification step. Due
to the placement of the patch, the sounds differed from standard heart auscultation and were contaminated
by respiratory sounds. Figure 6 gives a structural overview of the procedure.
Figure 6. ECG and PCG peak detection and classification of S1 and S2 candidates before PEP and
LVET estimation.
Within the original algorithm, we altered the thresholding phase from the original, signal-dependent,
but fixed threshold to a dynamic threshold calculated in 10 s windows using the standard deviation.
In order to robustify the PCG peak detection in the presence of noise, several additional processing steps
followed the raw detection phase detailed by Varghees et al., replacing the original S1 and S2 classification
approach. First, identified peak candidates were analyzed for completeness. For each peak candidate,
a start, local maximum, and end had to be available. If one or more were missing, the candidate was
discarded. Using the ECG and the current heart rate, a window from each R-peak to 75% of the current
heart cycle length was defined where S1 and S2 candidates were identified. If exactly two peak candidates
were found in that window, the peak closer to the R-peak was defined as S1 and the second one as S2.
If less than two peaks were found, the peak was discarded. When more than two candidates were found
in the window, the peak closest to the R-peak was defined as S1, and the peak closest to the T-wave
was defined as S2. After peak detection and classification, the PEP was calculated from the ECG and
stethoscope as:
PEP(n) = tS1peak (n)− tQ(n), (7)
and the LVET as:
LVET(n) = tS2peak (n)− tS1peak (n), (8)
where tS1peak (n), tQ(n), and tS2peak (n) are vectors containing the temporal location in seconds of the
respective elements for each heartbeat n. S1peak and S2peak are the peaks of the heart sounds S1 and S2,
respectively, and Q is the Q-wave of the QRS complex of the ECG.
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2.6. Electrocardiogram- and Phonocardiogram-Derived Respiration
We derived respiratory surrogates from both the ECG, using ECG-derived respiration (EDR)
techniques, and the PCG, using our proposed novel method of PCG-derived respiration (PDR). We
used the ECG and PCG signals, as well as their previously described fiducial points. Table 1 gives an
overview of the twelve employed features.
Table 1. ECG- and PCG-derived respiration features.
Feature Class Source Signals Feature Symbol Description
Timing ECG HR Heart rate
Timing PCG LVET Left ventricular ejection time
Timing ECG, PCG PEP Pre-ejection period
Area ECG QRSarea QRS complex area
Area PCG S1area S1 area
Area PCG S2area S2 area
Amplitude ECG QRSamp QRS complex amplitude
Amplitude PCG S1amp S1 amplitude
Amplitude PCG S2amp S2 amplitude
Morphology ECG QRSPCA Morphological variations of the QRS complex
Morphology PCG S1PCA Morphological variations of the S1 peak
Morphology PCG S2PCA Morphological variations of the S2 peak
The EDR and PDR features can be divided into four classes: timing based (HR, LVET, PEP), area
based (QRSarea, S1area, S2area), amplitude based (QRSamp, S1amp, S2amp), and morphology based (QRSPCA,
S1PCA, S2PCA). The definitions of PEP and LVET are given in Equations (7) and (8). The heart rate (HR) in
beats per minute at the current beat n was calculated from the location of the R-peaks of the ECG as:
HR(n) = 60
s
min
∗ 1
tR(n)− tR(n− 1) , (9)
where tR(n) is the time of the R-peak in beats n in seconds. The area based features were calculated in
windows of length 2 ∗QRSwind, 2 ∗ S1wind, and 2 ∗ S2wind around the ECG, S1, and S2 peaks, respectively.
The QRS window length was set to 250 ms. The S1 and S2 window lengths were the average S1 and S2
segment lengths for each analyzed subject. The beat-to-beat areas were then calculated as:
QRSarea(n) =
∫ tQRSpeak (n)+QRSwind
tQRSpeak (n)−QRSwind
|ECG(t)|dt, (10)
S1area(n) =
∫ tS1peak (n)+S1wind
tS1peak (n)−S1wind
|PCG(t)|dt, (11)
and:
S2area(n) =
∫ tS2peak (n)+S2wind
tS2peak (n)−S2wind
|PCG(t)|dt. (12)
The PCG amplitude features S1amp and S2amp were calculated as the difference between the maximum
and the minimum in the respective peak’s window. The ECG amplitude feature QRSamp was defined as
the R-to-S amplitude.
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For the morphology based features, the linear principal component analysis (PCA) was calculated
over the previously defined windows of the respective signals. In the ECG case, the Eigenvector with the
largest Eigenvalue strongly corresponded to the respiration and could therefore be used as a morphology
based feature [54]. We adopted this approach for the S1 and S2 peaks in addition to the QRS complex.
The resulting twelve beat-to-beat feature vectors were then up-sampled to 20 Hz using linear
interpolation. The first derivative of the up-sampled signals was low-pass filtered using a zero-phase FIR
filter with an order of 200 at a corner frequency of 1 Hz. A 0.05 Hz baseline was removed. Figure 7 gives
an overview of the processing steps.
Figure 7. Beat-to-beat (B2B) ECG and PCG derived respiration for estimating the respiratory flow Fˆ and
rate RˆR using the estimated ECG and the PCG signals in a model and feature selection framework.
The resulting twelve EDR and PDR feature vectors were processed in a nested cross-validation
model and feature selection framework similar to that discussed in [55]. Using the models presented in
Section 2.2, features were selected by a forward wrapping approach. For each model-feature combination,
cross-validated performances of the estimated flow signal Fˆ and respiratory rate RˆR relative to the SOMNO
HD reference respiratory flow F and rate RR were calculated. Based on the linear correlation between
F and Fˆ and the respiratory rate estimation error, the optimal model-feature combinations were found.
Respiratory rates were estimated in 30 s windows with 50% overlap using the maximum of the FFT
between 4 and 40 bpm.
3. Results
3.1. Einthoven Lead Estimation
The results of the model selection step for the ECG lead estimation are visualized in Figure 8a–c.
As both polynomial models, as well as MLPs performed significantly worse than TDNNs, only a selection
of the results of the TDNNs is shown. The optimal polynomial model was of the order of nine. The optimal
MLP model consisted of three layers with twelve neurons each. In (a), dashed lines represent models with
the same lag parameters. It became apparent that increasing the maximum lag significantly decreased the
BIC. Increasing the model complexity in the hidden layers while keeping the lag parameters constant had
a smaller impact on the BIC. In (c), the average BIC over maximum model lag is given. It became evident
that a lag value of 70 to 80 was optimal. In (b), the lowest points of the BIC curves are given. Based on that
criterion, the TDNN with three hidden layers and nine neurons each with a delay line of zero to 80 lags
was the optimal model and was therefore chosen for subsequent ECG analysis.
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Figure 8. BIC model selection for Einthoven ECG lead estimation, TDNNs only: (a) Selection of models
and lines of constant lag length. (b) Minimum BIC values. (c) BIC over the number of delay line lags.
The average ECG estimation performances over all subjects and positions are given in Table 2 for
the optimal model of each of the three model classes. In general, MLPs increased the performance only
slightly compared to polynomial models. Using TDNNs however, the performance increased significantly.
With the optimal TDNN model, the estimation of the second Einthoven lead showed a linear correlation
of 0.99 and a relative error of 5.5%. A slightly lower correlation was achieved for the first Einthoven
lead, which showed a linear correlation of 0.97 and a relative error of 1.6%. No significant performance
differences between the supine, lateral, and prone position were observed.
Table 2. Performances of the Einthoven I and II ECG lead estimations from the patch ECG for the optimal
polynomial, MLP, and TDNN models.
Target ECG Lead Model MEµV MAEµV r NMSE%
Einthoven I Poly 0.00± 0.58 30.6± 10.7 0.67± 0.18 52± 24
Einthoven I MLP 0.09± 0.09 29.5± 10.4 0.69± 0.17 50± 22
Einthoven I TDNN 0.11± 0.51 9.60± 3.10 0.97± 0.04 5.5± 7.0
Einthoven II Poly 0.20± 2.70 114± 49.5 0.75± 0.15 42± 21
Einthoven II MLP 0.28± 3.5 110± 37 0.77± 0.14 40± 20
Einthoven II TDNN 0.70± 1.20 23.80± 5.7 0.99± 0.00 1.6± 0.6
Figures 9 and 10 show ECG excerpts of two different subjects in the supine position at the same time
within the measurement protocol. In (a), the 55 mm patch ECG is shown; (b) and (c) show the reference
Einthoven leads, as well as the estimated ECG signals. While the Einthoven leads were comparable
between the two subjects, the patch ECG leads differed considerably. Throughout our investigations,
we observed high intersubject variability of the patch ECG lead morphology. Despite these variations,
the Einthoven leads could always be estimated with the given performance.
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Figure 9. Example ECG signals of Subject 1 in the supine position: (a) Patch ECG. (b) Reference and
estimated Einthoven I ECGs. (c) Reference and estimated Einthoven II ECGs.
Figure 10. Example ECG signals of Subject 2 in the supine position: (a) Patch ECG. A high intersubject
variability of the patch ECG lead can be observed when compared to Figure 9a. (b) Reference and estimated
Einthoven I ECGs. (c) Reference and estimated Einthoven II ECGs.
3.2. PEP and LVET Estimation
Figure 11 exemplarily shows an ECG and PCG signal excerpt with the detected fiducial points within
a simulated apnea phase. The ECG peak detection performed well over all signals due to the high signal
quality. In the PCG, the starts and peaks for both S1 and S2 were detected consistently. The duration of the
S1 and S2 peaks tended to be under-estimated slightly, due to relatively early S1 end and S2 end detection.
In low signal quality scenarios, especially in deeper breathing phases, the PCG peak detection performance
was reduced due to the additional noise introduced by the lung sounds. The most common problem was
the detection of false peaks, which was reduced by the additional ECG information in the classification
phase. In 85.8% of the total stethoscope data, two PCG peaks were identified using the proposed combined
ECG and PCG peak detection approach. The lateral position performed best with 89.8%, followed by the
supine position with 81.9%. In the prone position, 75.8% of the data were usable for PCG peak detection.
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Figure 11. ECG and PCG signals with detected fiducial points.
In Table 3, the results of the PEP and LVET estimations for the lateral position are given, as it
resembled the typical echocardiography positioning for which published performances were available.
In this position, PEP was estimated with an error of 16.1%. The relative LVET estimation error was 7.0%.
For long-term ambulatory estimations, however, other positions were of interest as well. We found that
the performance of the LVET and PEP estimations differed between different positions. Over all positions
and subjects, the PEP was estimated with an ME of 0.4 ms and an MAE of 25.1 ms, which translated to
21.3% relative error. The LVET was estimated with an ME of −3.6 ms and an MAE of 30.5 ms, which was a
relative error of 10.0%.
Table 3. PEP and LVET estimation results for aortic area auscultation and ECG signals in the lateral position.
Position STI MEms MAEms MAPE%
Lateral PEP 6.18± 24.36 17.61± 17.92 16.06± 16.16LVET −3.55± 32.07 21.81± 23.78 7.01± 7.64
Figure 12 shows Bland–Altman plots of the STI estimates for PEP (a) and LVET (b). The mean
reference PEP was 111.4 ms, and the mean reference LVET was 303.4 ms. The visible quantization was a
result of the 5 ms resolution of the PEP and LVET reference values from the ICON-Core. The PEP plot
shows a series of positive outliers above 150 ms, while in the LVET plot, outliers are more commonly
negative and located below 275 ms. Otherwise, no strong trend became evident in the error.
Figure 12. Bland–Altman plots of the STI estimates. (a) PEP. (b) LVET.
3.3. Electrocardiogram- and Phonocardiogram-Derived Respiration
Optimizing the model and feature selection based on the correlation of the estimated flow signal r f low,
a TDNN with two hidden layers, two neurons each, and a tap delay vector of zero to nine was chosen. Out
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of the twelve available EDR and PDR features, HR,QRSarea, S1PCA, and QRSamp were selected. Optimizing
for a minimal MAE of the respiratory rate estimation MAEbpm, a two-layer TDNN with four neurons each
and a tap delay line with lags of zero to 14 performed best, and the features HR,QRSamp, S1amp, LVET,
and QRSPCA were selected. In Tables 4 and 5, the performances of the respiratory signal and rate
estimations relative to the flow reference are given. Data are shown for the two optimization criteria and
individually for all positions with outliers removed. A data point was deemed an outlier if its distance to
the median was larger than three scaled median absolute deviations.
Table 4. Performances of the respiratory signal and rate estimations in the individual positions for maximum
r f low feature selection optimization. The percentage of outliers removed is given.
Position rflow MEbpm MAEbpm rRR MAPE% Outliers%
supine 0.75± 0.09 −0.01± 0.23 0.18± 0.15 0.91± 0.07 1.46± 1.43 9.60
lateral 0.66± 0.11 −0.05± 0.30 0.23± 0.20 0.85± 0.03 1.89± 1.93 15.34
prone 0.51± 0.10 0.04± 0.50 0.35± 0.36 0.76± 0.11 3.30± 3.91 22.73
all 0.66± 0.14 −0.03± 0.29 0.22± 0.19 0.85± 0.09 1.86± 1.95 16.60
Table 5. Performances of the respiratory signal and rate estimations in the individual positions for minimum
MAEbpm feature selection optimization. The percentage of outliers removed is given.
Position rflow MEbpm MAEbpm rRR MAPE% Outliers%
supine 0.71± 0.10 0.01± 0.26 0.20± 0.16 0.92± 0.06 1.64± 1.57 9.60
lateral 0.62± 0.13 −0.05± 0.29 0.21± 0.20 0.87± 0.06 1.83± 1.96 14.20
prone 0.48± 0.11 0.00± 0.45 0.34± 0.29 0.79± 0.05 3.14± 3.21 20.45
all 0.62± 0.14 −0.02± 0.33 0.25± 0.22 0.87± 0.08 2.13± 2.25 12.06
In both optimization scenarios, the RR estimation bias was close to zero. The RR estimation error was
slightly lower for the corresponding optimized feature selection. The flow signal correlation was higher
for the correlation optimized feature set. A consistent finding was the position-dependent performance
of all parameter estimations with the supine position performing best, followed by the lateral and the
prone position. The relative error more than doubled between the supine and prone position, and
the flow correlation was reduced from 0.75 to 0.51. In addition, the number of outliers was highly
dependent on the probands’ position. Again, in the supine position, the least amount of outliers were
detected. Without outlier removal, the average performance over all postures for the RR estimation was
ME = −0.40± 3.57 bpm, MAE = 1.20± 3.38 bpm, rRR = 0.87± 0.08, and MAPE = 8.15± 23.55%.
The best performing individual feature without outlier removal was the HR with a flow correlation of
0.55± 0.10, an RR ME of −0.45± 1.62 bpm, an RR MAE of 1.88± 1.16 bpm, an RR MAPE of 13.21 ± 27.4%,
and an RR correlation of 0.82± 0.14.
Figure 13a,b shows Bland–Altman plots of the respiratory rate estimations including all positions for
the two optimization targets and without outlier removal. The three distinct respiratory frequencies of
the study protocol became apparent. The lower and higher respiratory frequencies were more prone to
outliers, while no directly rate-dependent error dependency was found.
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Figure 13. Performance plots of the EDR and PDR based RR estimations over all positions including
outliers. (a) Correlation optimization. (b) Respiration rate optimization.
Figure 14 gives an example of a reference and estimated respiratory flow in two different breathing
phases. The estimated breathing signal followed the frequency change and also adapted to the varying
breathing depths over time. The more detailed, transient behavior was captured less effectively due to the
beat-to-beat nature of the underlying feature basis.
Figure 14. Example reference and estimated respiratory signal using ECG- and PCG-derived respiration.
4. Discussion
Estimating Einthoven I and II ECG leads from a single 55 mm patch ECG yielded errors below
6% with correlation coefficients above 0.97. This finding confirmed the assumption for Einthoven I and
II made by Lee et al. that an ECG patch system of that size could be used to estimate standard ECG
leads [20]. By using only a single lead instead of multiple neighboring leads, an important additional
restriction was introduced in our work, which further reduced the system complexity. However, in our
investigations, linear and MLP models did perform similar to each other and did not reach the performance
reported by Lee et al. By introducing TDNNs, similar performance values were achieved. We assume
that by using multiple leads oriented differently on the body surface in their regression models, Lee et al.
effectively added additional information that was not available in our single-lead approach. However,
we can report that for Einthoven I and II, this missing information could be extracted from a single lead,
thus removing the need for additional leads. Reviewing patient-specific data, a large morphological
inter-subject variability of the minimal ECG lead was found, even though great care was taken applying
the patch system in the same position for every subject. We must therefore assume that it is best practice to
learn subject-specific regression models and therefore recommend an individualized approach. Future
research could analyze the possibility of finding models able to generalize over subjects or cohorts.
The estimation of PEP and LVET from the wearable stethoscope and transformed ECG yielded errors
of 10% for LVET and 21% for PEP over all subject positions. In the lateral positions, errors were 7% and
16%, respectively, highlighting the high position dependency of the estimation. The positive PEP and
negative LVET outliers reported could be explained by a suboptimal S1 peak detection. The position of the
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S1 heart sound had a strict lower bound in its temporal position within the heart cycle. It could not be
observed before the Q-point of the ECG. In the presence of noise, the distribution of the S1 peak position
detection error had therefore a positive bias. Thus, the S1 peak position tended to be over-estimated. Given
Equations (7) and (8), it then became plausible that PEP would exhibit more positive and LVET more
negative outliers. Compared to the same position and for healthy subjects, the performances reported by
Paiva et al. were in the same range, whilst slightly higher [30]. Differences in the performance were most
likely due to the automated S1 and S2 annotation process, which suffered from the suboptimal placement
of the stethoscope system for the task of STI estimation due to lung sounds. While Paiva et al. placed the
stethoscope at the left sternal border, the placement of our patch was chosen according to a wider use-case
spectrum and an emphasis on adherence in an ambulatory setting, which resulted in a much larger lung
sound content and thus lower overall signal quality. It is worth noting though that similar placement
issues are foreseen in a wearable, multimodal sensor application, and therefore, the procedure simulated
typical use-cases and performances more accurately. Future research could further analyze the highly
subject position-dependent estimation performances and compare SCG and PCG based STI estimation in a
wearable context.
The respiratory rate was estimated by the ECG- and PCG-derived respiration algorithm with a mean
error of below −0.4 bpm and a mean absolute error below 1.2 bpm. The results were well within the
range of other wearable respiration estimation systems using the ECG and an additional sensor, such as
accelerometry [56]. The flow signal was estimated with a linear correlation of 0.66 relative to the flow
reference. Using the first Eigenvector of the QRS complex, Langley et al. reported correlations to a flow
signal of 0.58 [54]. Both the respiration rate and the flow estimation performances were dependent on the
subject position, while still giving acceptable results in all three examined postures. It is worth noting that
the number of outliers differed significantly between the three subject positions and mainly contributed
to the, otherwise small, deviations of the error distributions. Introducing the additional ECG and PCG
features compared to the single best ECG feature decreased the relative respiration estimation error from
13% to 8% and increased the flow correlation from 0.55 to 0.66. With an absolute respiration rate error below
1.2 bpm, the estimation of the respiratory signal itself, i.e., flow and tidal volume, should be emphasized
in future research to remove the burden of masks, belts, and nasal sensors in respiration measurements.
A limitation of the results discussed is the number of subjects included in the study. A strength,
on the other hand, is that each subject was analyzed in the supine, lateral, and prone position for over
11 min each, yielding more than 5 h of total data and more than 20,000 beats automatically analyzed.
Due to the different subject positions, a more detailed analysis of the ambulatory use-case was possible.
In addition, a range of respiratory frequencies and depths, as well as simulated apneas were part of the
protocol. For the STI estimation, the reference system used an ECG-ICG approach, which is known to be
less accurate than echocardiography [29], and in the presented case had a resolution of only 5 ms. Despite
these limitations, the reference data stemmed from a clinically validated and approved medical device and
should therefore be adequately reliable.
5. Conclusions
The application of our wearable, multimodal digital patch stethoscope for ECG, PEP, LVET, as well
as respiratory rate and flow estimation was presented. It was shown that all three applications could be
covered using a 55 mm single lead ECG integrated into a patch stethoscope system in the supine, lateral,
and prone positions. In the case of Einthoven I and II, as well as the respiratory rate, the estimations
showed very good agreement with the reference systems. PEP and LVET estimation performances were
lower, but within the range of published results of other research groups. The slightly lower performances
most likely resulted from the suboptimal placement of the stethoscope for cardiac auscultation. From a
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signal processing point of view, the presented results leave room for further improvements. Clinically,
however, the correlations for LVET, PEP, and respiratory flow could be considered as very promising
as the good results are substantially beneficial to future patients due to the positive trade-off of being
non-invasive and not interfering with the respiration of the patients. Except for the ECG estimation, all
parameters exhibited strong subject position-dependent performances. We found strong morphologic
intersubject variability in all signals.
We concluded that the estimation of ECG, PEP, LVET, and respiratory parameters is possible based
on highly localized, multimodal acquisition systems including an ECG and a stethoscope. However, we
recommend deriving subject-specific regression models until more studies are available on generalized
intersubject or cohort regression models. Additional research should include the subject position
dependency of estimation quality. In order to assess the long-term applicability of the presented system
and methods, an evaluation by means of a full polysomnography in parallel with our patch device will be
needed. Finally, respiratory signal, flow, and tidal volume estimation appear to be the next logical step
after respiratory rate estimation to be able to assess the respiratory apparatus without masks, belts, or
nasal sensors. We hope to further motivate and accelerate the development of truly multimodal acquisition
systems that would enable the holistic long-term monitoring approach needed to tackle the cardiovascular
and respiratory challenges of the future.
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Abbreviations
The following abbreviations are used in this manuscript:
B2B Beat-to-beat
BIC Bayesian information criterion
bpm Breaths per minute
CVD Cardiovascular disease
ECG Electrocardiogram
EDR Electrocardiogram-derived respiration
FFT Fast Fourier transform
ICG Impedance cardiography
ICS Intercostal space
LVET Left ventricular ejection time
MDPI Multidisciplinary Digital Publishing Institute
MAE Mean absolute error
MAPE Mean absolute percentage error
MARG Magnetic, angular rate, and gravity
ME Mean error
MERS Middle East respiratory syndrome
MLP Multi-layer perceptron
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NMSE Normalized mean squared error
PCA Principal component analysis
PCB Printed circuit boards
PCG Phonocardiogram
PDR Phonocardiogram-derived respiration
PEP Pre-ejection period
PPG Photoplethysmogram
RR Respiratory rate
SARS Severe acute respiratory syndrome
SCG Seismocardiogram
SSE Sum of squared errors
STI Systolic time intervals
TDNN Time-delay neural network
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